Mucosal immune disorders lead to IBD as a result of TLR4 activation results in NF‐κB activation and cytokine expression in macrophages.32 We investigated if lentinan inhibited lipopolysaccharide (LPS)‐stimulated TLR4 signalling and reduced IBD progression. Here, NFKB1 is linked to inflammatory bowel disease.